Skip to main content
Log in

Release of norepinephrine and dopamine from brain vesicular preparations: Effects of calcium antagonists

  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Summary

  1. 1.

    The calcium antagonists D-600 (1–10µM) and diltiazem (10–25µM) inhibit K+-evoked release of [3H]norepinephrine from guinea pig cerebral cortical vesicular preparations. The inhibition of release is partially reversed by increasing concentrations of calcium to 2 mM. Diltiazem at 100µM has no effect on K+-evoked release of [3H]norepinephrine at 0.15 mM calcium but does inhibit release at 2.0 mM calcium.

  2. 2.

    The calcium antagonist nifedipine and dantrolene, an agent purported to antagonize release of calcium from intracellular storage sites, have no effect on K+-evoked release of [3H]norepinephrine.

  3. 3.

    The calcium antagonists D-600 (1µM) and diltiazem (10µM) inhibit K+-evoked release of [3H]dopamine from guinea pig striatal vesicular preparations. Higher concentrations of drug, namely, 10µM for D-600 and 100µM for diltiazem, cause a potentiation rather than an inhibition of K+-evoked release. The potentiation is reduced in magnitude upon raising the extracellular calcium to 2.0 mM. Indeed, 10µM D-600 then inhibits K+-evoked release of [3H]dopamine.

  4. 4.

    The results indicate that putative calcium antagonists can have both inhibitory and facilitory effects on calcium-dependent K+-evoked release of catecholamines from central synaptic endings. Furthermore, certain peripheral calcium antagonists such as nifedipine and dantrolene may prove ineffective in central systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Atlas, D., and Adler, M. (1981).α-Adrenergic antagonists as possible calcium channel inhibitors.Proc. Natl. Acad. Sci. USA 781237–1241.

    Google Scholar 

  • Desmedt, J. E., and Hainaut, K. (1977). Inhibition of the intracellular release of calcium by dantrolene in barnacle giant muscle fibers.J. Physiol. 265565–585.

    Google Scholar 

  • Durant, N. N., Lee, C., and Katz, R. L. (1980). The action of dantrolene on transmitter mobilization of the rat neuromuscular junction.Eur. J. Pharmacol. 68403–408.

    Google Scholar 

  • Ebstein, R. P., and Daly, J. W. (1982). Release of norepinephrine and dopamine from brain vesicular preparations: Effects of adenosine and analogues.Cell. Mol. Neurobiol. 2193–204.

    Google Scholar 

  • Ebstein, R. P., Seamon, K., Creveling, C. R., and Daly, J. W. (1982). Release of norepinephrine from brain vesicular preparations: Effects of an adenylate cyclase inhibitor, forskolin, and a phosphodiesterase inhibitor.Cell. Mol. Neurobiol. 2179–192.

    Google Scholar 

  • Fairhurst, A. S., Whittaker, M. L., and Ehlert, F. J. (1980). Interactions of D600 (methoxyverapamil) and local anesthetics with rat brainα-adrenergic and muscarinic receptors.Biochem. Pharmacol. 29155–162.

    Google Scholar 

  • Fleckenstein, A. (1977). Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.Annu. Rev. Pharmacol. Toxicol. 17149–166.

    Google Scholar 

  • Galper, J. B., and Catterall, W. A. (1979). Inhibition of sodium channels by D600.Mol. Pharmacol. 15174–178.

    Google Scholar 

  • Ichida, S., Okada, K., and Terao, M. (1980). Effect of verapamil on Ca-45 uptake by synaptosomes.Jap. J. Pharmacol. 30207–213.

    Google Scholar 

  • Llinas, R. R., and Heuser, J. E. (1977). Depolarization-release coupling systems in neurons.Neurosci. Res. Progr. Bull. 15557–687.

    Google Scholar 

  • McGee, R., Jr., and Schneider, J. E. (1979). Inhibition of high affinity synaptosomal uptake systems by verapamil.Mol. Pharmacol. 16877–885.

    Google Scholar 

  • Meszaros, J., Kecskemeti, V., and Szegi, J. (1981). Effect of dantrolene sodium on the transmembrane potentials and contractility of guinea pig atrial myocardium.Eur. J. Pharmacol. 74181–188.

    Google Scholar 

  • Miledi, R., and Parker, I. (1981). Diltiazem inactivates acetylcholine-induced membrane channels in skeletal muscle fibres.Biomed. Res. 2587–599.

    Google Scholar 

  • Mulder, A. H., De Langen, C. D. J., De Regt, V., and Hogenboom, F. (1978). Alpha-receptor mediated modulation of3H-noradrenaline release from rat brain cortex synaptosomes.Naunyn-Schmiedeberg's Arch. Pharmacol. 303193–196.

    Google Scholar 

  • Rahamimoff, R. (1976). The role of calcium in transmitter release at the neuromuscular junction. InMotor Innervation of Muscle (Thesleff, S., Ed.), Academic Press, New York, pp. 117–199.

    Google Scholar 

  • Rahwan, R. G., Piascik, M. F., and Witiak, D. T. (1979). The role of calcium antagonism in the therapeutic action of drugs.Can. J. Physiol. Pharmacol. 57443–459.

    Google Scholar 

  • Salata, J. J., and Jalife, J. (1982). Effects of dantrolene sodium on the electrophysiological properties of canine cardiac Purkinje fibers.J. Pharmacol. Exp. Ther. 220157–166.

    Google Scholar 

  • Sengupta, D., Meyer, U. A., and Carafoli, E. (1980). Binding of dantrolene sodium to muscle intracellular membranes.FEBS Lett. 11737–38.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebstein, R.P., Daly, J.W. Release of norepinephrine and dopamine from brain vesicular preparations: Effects of calcium antagonists. Cell Mol Neurobiol 2, 205–213 (1982). https://doi.org/10.1007/BF00711148

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00711148

Key words

Navigation